Updated Clinical Results and New Biomarker Analyses Presented for Daiichi Sankyo\'s DS1062 in Patients with Advanced NSCLC at 2019 World Conference on Lung Cancer

Updated Clinical Results and New Biomarker Analyses Presented for Daiichi Sankyo's DS-1062 in Patients with Advanced NSCLC at 2019 World Conference on Lung Cancer

- Updated results presented for investigational TROP2 targeting ADC DS-1062 in unselected patients with unresectable advanced NSCLC who are refractory to or have relapsed following standard treatm...

More From BioPortfolio on "Updated Clinical Results and New Biomarker Analyses Presented for Daiichi Sankyo's DS-1062 in Patients with Advanced NSCLC at 2019 World Conference on Lung Cancer"